CureApp is a digital health startup
CureApp is a digital health startup.The firm is one of the leading players in the medical app vertical under the theme of “app exhibits therapeutic effects against diseases” and launched a nicotine addiction treatment app in February 2015, which was jointly developed with Division of Pulmonary Medicine, Keio University’s School of Medicine. It is currently conducting clinical trials in many locations.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 12, 2021 | Series D | ¥2.10B | 2 | — | — | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
SIIF
|
— | Series D |
Healthcare Innovation
|
— | Series D |